Breakthrough in heart failure with preserved ejection fraction: are we there yet?
Shir Lynn Lim, Carolyn Su Ping Lam
Korean J Intern Med. 2016;31(1):1-14. Published online 2015 Dec 28 DOI: https://doi.org/10.3904/kjim.2016.31.1.1
Citations to this article as recorded by 
The vasculature: a therapeutic target in heart failure?
Guillermo Luxán, Stefanie Dimmeler
Cardiovascular Research.2022; 118(1): 53. CrossRef
Immunomodulation in Heart Failure with Preserved Ejection Fraction: Current State and Future Perspectives
Elise L. Kessler, Martinus I.F.J. Oerlemans, Patricia van den Hoogen, Carmen Yap, Joost P.G. Sluijter, Saskia C.A. de Jager
Journal of Cardiovascular Translational Research.2021; 14(1): 63. CrossRef
Attitudes toward advance directives and prognosis in patients with heart failure: a pilot study
JinShil Kim, Minjeong An, Seongkum Heo, Mi-Seung Shin
The Korean Journal of Internal Medicine.2020; 35(1): 109. CrossRef
Emerging role of SIRT3 in endothelial metabolism, angiogenesis, and cardiovascular disease
Xiaochen He, Heng Zeng, Jian‐Xiong Chen
Journal of Cellular Physiology.2019; 234(3): 2252. CrossRef
Memory loss and decreased executive function are associated with limited functional capacity in patients with heart failure compared to patients with other medical conditions
JinShil Kim, Mi-Seung Shin, Seon Young Hwang, Eunok Park, Young-Hyo Lim, Jae Lan Shim, Sun Hwa Kim, Yeon Hee Kim, Minjeong An
Heart & Lung.2018; 47(1): 61. CrossRef
Palliative and end-of-life care for heart failure patients in an aging society
Takahiro Okumura, Akinori Sawamura, Toyoaki Murohara
The Korean Journal of Internal Medicine.2018; 33(6): 1039. CrossRef
Commentary: Heart Failure with Preserved Ejection Fraction Induces Beiging in Adipose Tissue
Salvatore Chirumbolo
Frontiers in Physiology.2016;[Epub] CrossRef